{"id":153299,"title":"Updated recommendations for the use of varicella zoster immune globulin (VarIg) for the prevention of varicella in at-risk patients - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2025-04-18","captureTimestamp":"2025-04-18T12:20:56.319000+00:00","jobId":1,"originalUrl":"https://www.canada.ca/en/public-health/services/publications/healthy-living/updated-recommendations-use-varicella-zoster-immune-globulin-varig-prevention-varicella-risk-patients.html","snippet":"Updated recommendations for the use of varicella zoster immune globulin (VarIg) for the prevention of varicella in at-risk patients - Canada.ca Skip to main content Skip to \"About government\" Language selection Français fr / Gouvernement du Canada Search Search Canada.ca Search…","rawSnapshotUrl":"/api/snapshots/raw/153299","browseUrl":"https://replay.healtharchive.ca/job-1/20250418122056/https://www.canada.ca/en/public-health/services/publications/healthy-living/updated-recommendations-use-varicella-zoster-immune-globulin-varig-prevention-varicella-risk-patients.html#ha_snapshot=153299","mimeType":"text/html","statusCode":200}